Authors
Latest:
Screen Saver: Simpler, Less Costly Virus Testing in High-Risk SettingsScreening for an immunological biomarker in the nasal passage can effectively rule out a respiratory virus — reducing the need for conventional PCR tests.
Latest:
A Review of the Currently Available Monoclonal Antibodies for COVID-19Outside of vaccines, these underutilized therapies are the best defense against severe disease.
Latest:
Celebrating 30 Years: The Past, Present, and Future of the Society of Infectious Diseases Pharmacists (SIDP)Introducing “Bench to Bedside With SIDP,” a new column covering everything from antimicrobial stewardship and pharmacokinetics/pharmacodynamics to mentorship, preceptorship, and more.
Latest:
A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral NeglectSimilar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.
Latest:
Merck's Clesrovimab Shows Effectiveness in RSV Prevention for InfantsAnushua Sinha, MD, discussed the findings, highlighting a 60.4% reduction in medically attended lower respiratory infections and significant decreases in RSV-related hospitalizations.
Latest:
SPREADing the Love: The Importance of Mentorship in PharmacyIn the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.
Latest:
Restarting Therapy in Patients with HIVAddressing patients with HIV who have fallen out of care, Shauna Applin, ARNP, provides clinical insights on treatment options and best practices for restarting therapy.
Latest:
Fidaxomicin Use Remains Flat Despite Guideline Change for C difficile TreatmentAt MAD-ID 2025, Dakota Rorie, PharmD, highlights cost and access barriers to uptake of preferred CDI therapy.
Latest:
Tuberculosis Meningitis in an Immunocompetent PatientRead more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.
Latest:
Aging in HIV: A Review of Common Comorbidities in People Living With HIVThis review highlights how people living with HIV are living longer due to antiretroviral therapy but face unique age-related health challenges, including cardiovascular disease, metabolic syndrome, renal dysfunction, neurocognitive decline, immunosenescence, bone loss, and frailty, requiring tailored screening and management strategies.
Latest:
Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile InfectionsTo close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Latest:
AASLD/IDSA Develop a New Algorithm for Hepatitis C Point of Care Testing and TreatmentAndrew Aronsohn, MD, associate professor of Medicine, University of Chicago Medical Center, discusses the hepatitis C (HCV) screen and treat plan that looks to utilize a one visit approach to get people tested and on medication in the same patient encounter.
Latest:
A Case of Varicella-Zoster Meningitis Causing Postoperative Fevers After Umbilical Hernia RepairDue to worsening headaches and unrevealing cross-sectional imaging and ascites fluid analyses, this patient's differential evolved toward a central nervous system source.
Latest:
Are We at a Breaking Point for Adoption of Updated Susceptibility Interpretive Criteria?The implementation of new College of American Pathologists rules presents an opportunity for collaboration between clinical microbiology laboratories and infectious disease pharmacists and physicians.
Latest:
Impact of Obesity on Antibiotic Treatment OutcomesPresented at MAD-ID by Mohammed Al Musawa, PharmD, BCIDP, the study found lower clinical success with imipenem-cilastatin-relebactam in obese patients, raising questions about dosing strategies.
Latest:
Ceftriaxone Dosing: Once or Twice Daily?In the latest column from SIDP, clinicians discuss that along with the once-daily dosing for many indications, there are also compelling indications for twice-daily dosing.
Latest:
Early Experience With the BioFire Pneumonia PanelA balance between antimicrobial stewardship and the search for multidrug-resistant organisms.
Latest:
Considering the Impact of Crop Spraying and Antifungal ResistanceAt the ASM Microbe conference, Mike Bromley, PhD, offers some insights on the importance of a One Health approach addressing the growing antifungal resistance to azoles and Aspergillus fumigatus because of the connection between crop spraying and the rise of resistance.
Latest:
Honoring Her Daughter’s Legacy After a Long-Standing Battle With Antimicrobial ResistanceAfter Diane Shader Smith lost her daughter, Mallory, to a multidrug resistant infection, she turned her personal tragedy into a mission designed to inform people about antimicrobial resistance (AMR), and have the public coalesce around this expanding medical issue.
Latest:
Ethical and Innovative Use of AI in Infectious DiseasePatient-centered innovation amidst evolving regulations and policies is a key strategy.
Latest:
Strengthening Observational Studies: Community Engagement and Data PracticesEmily Ricotta, PhD, MSc outlines the importance of involving affected populations and refining data collection methods to improve early decision-making during epidemics
Latest:
Increase in Enteroviruses Seen with Decreases in COVID-19 PrecautionsThe Centers for Disease Control and Prevention (CDC) reports the rise in pediatric acute respiratory illnesses especially as there is a decrease in hygiene measures that were previously employed during the pandemic.
Latest:
Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile InfectionsTo close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Latest:
The FRESH Study Tests New HIV Remission Strategy in South African WomenThumbi Ndung'u, BVM, PhD discussed the safety and partial virologic control observed in a Phase 2a trial using broadly neutralizing antibodies and vesatolimod in HIV treatment interruption.
Latest:
Looking for COVID-19 Vaccine Guidance? Other Clinicians Are as WellIn the second installment of our conversation with Jeremy Faust, MD, he addresses the uncertainty surrounding guidance and where to turn for information.
Latest:
A Chance to Improve Hepatitis C Care for PWIDHere is a review of an opportunistic treatment approach to HCV infection in this patient population in a European study and some of the potential challenges in applying it in the United States.
Latest:
Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of PatientsArbutus CEO Michael McElhaugh discussed trial results showing that a combination of imdusiran, an RNAi therapeutic, and pegylated interferon alfa-2α can achieve a functional cure in chronic hepatitis B patients.
Latest:
High-Resistance Therapy Options for Treatment-Naïve Patients With HIVJoseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.
